Cargando…

The ReIMAGINE prostate cancer risk study protocol: A prospective cohort study in men with a suspicion of prostate cancer who are referred onto an MRI-based diagnostic pathway with donation of tissue, blood and urine for biomarker analyses.

INTRODUCTION: The ReIMAGINE Consortium was conceived to develop risk-stratification models that might incorporate the full range of novel prostate cancer (PCa) diagnostics (both commercial and academic). METHODS: ReIMAGINE Risk is an ethics approved (19/LO/1128) multicentre, prospective, observation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marsden, Teresa, McCartan, Neil, Brown, Louise, Rodriguez-Justo, Manuel, Syer, Tom, Brembilla, Giorgio, Van Hemelrijck, Mieke, Coolen, Ton, Attard, Gerhardt, Punwani, Shonit, Moore, Caroline M., Ahmed, Hashim U., Emberton, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870538/ https://www.ncbi.nlm.nih.gov/pubmed/35202397 http://dx.doi.org/10.1371/journal.pone.0259672

Ejemplares similares

The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate Cancer
por: Santaolalla, Aida, et al.
Publicado: (2021)

ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI
por: Marsden, Teresa, et al.
Publicado: (2021)

ReIMAGINE: a prostate cancer research consortium with added value through its patient and public involvement and engagement
por: Green, S., et al.
Publicado: (2021)

Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study
por: Norris, Joseph M., et al.
Publicado: (2021)

Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study [Image: see text] ()
por: Stavrinides, Vasilis, et al.
Publicado: (2020)

Emerging methods for prostate cancer imaging: evaluating cancer structure and metabolic alterations more clearly
por: Retter, Adam, et al.
Publicado: (2021)

AutoProstate: Towards Automated Reporting of Prostate MRI for Prostate Cancer Assessment Using Deep Learning
por: Mehta, Pritesh, et al.
Publicado: (2021)

Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study
por: Brembilla, Giorgio, et al.
Publicado: (2022)

Artificial Intelligence Compared to Radiologists for the Initial Diagnosis of Prostate Cancer on Magnetic Resonance Imaging: A Systematic Review and Recommendations for Future Studies
por: Syer, Tom, et al.
Publicado: (2021)

The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy
por: Simmons, Lucy A M, et al.
Publicado: (2017)

Prostate MRI quality: a critical review of the last 5 years and the role of the PI-QUAL score
por: Giganti, Francesco, et al.
Publicado: (2022)

Understanding PI-QUAL for prostate MRI quality: a practical primer for radiologists
por: Giganti, Francesco, et al.
Publicado: (2021)

Granulomatous prostatitis with high suspicion of prostatic adenocarcinoma on radiological imaging
por: Ambe, Yoshiki, et al.
Publicado: (2021)

Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial
por: Giganti, Francesco, et al.
Publicado: (2021)

The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk Stratification
por: Hamid, Sami, et al.
Publicado: (2019)

Prostate cancer diagnostic pathway: Is a one-stop cognitive MRI targeted biopsy service a realistic goal in everyday practice? A pilot cohort in a tertiary referral centre in the UK
por: Bass, Edward James, et al.
Publicado: (2018)

PROMIS — Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer()
por: El-Shater Bosaily, A., et al.
Publicado: (2015)

Editorial Comment to Granulomatous prostatitis with high suspicion of prostatic adenocarcinoma on radiological imaging
por: Sekito, Takanori, et al.
Publicado: (2021)

Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease?
por: Giganti, Francesco, et al.
Publicado: (2022)

“Textural analysis of multiparametric MRI detects transition zone prostate cancer”
por: Sidhu, Harbir S., et al.
Publicado: (2016)

A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocol
por: Kasivisvanathan, Veeru, et al.
Publicado: (2017)

Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer
por: Nowinski, Salpie, et al.
Publicado: (2018)

Logistic regression model for diagnosis of transition zone prostate cancer on multi-parametric MRI
por: Dikaios, Nikolaos, et al.
Publicado: (2014)

Expectant management in genitourinary malignancies (prostate, bladder, kidney)
por: Van Hemelrijck, Mieke, et al.
Publicado: (2021)

Oligometastatic prostate cancer: Reality or figment of imagination?
por: Foster, Corey C., et al.
Publicado: (2018)

Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study
por: Giganti, Francesco, et al.
Publicado: (2019)

Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base—a refined prostate cancer trajectory
por: Van Hemelrijck, Mieke, et al.
Publicado: (2016)

Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges
por: Trujillo, Blanca, et al.
Publicado: (2022)

Long-term biopsy outcomes in prostate cancer patients treated with external beam radiotherapy: a systematic review and meta-analysis
por: Singh, Saurabh, et al.
Publicado: (2021)

Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort
por: Giganti, Francesco, et al.
Publicado: (2020)

Mental Health in Northern Ireland—Laws Ancient and Modern
por: McCartan, William
Publicado: (1963)

Heterogeneity in risk of prostate cancer: A Swedish population‐based cohort study of competing risks and Type 2 diabetes mellitus
por: Häggström, Christel, et al.
Publicado: (2018)

Focal HIFU therapy for anterior compared to posterior prostate cancer lesions
por: Huber, Philipp M., et al.
Publicado: (2020)

Research engagement among black men with prostate cancer
por: Toms, Charlotte, et al.
Publicado: (2016)

Mapping PSA density to outcome of MRI-based active surveillance for prostate cancer through joint longitudinal-survival models
por: Stavrinides, Vasilis, et al.
Publicado: (2021)

MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial
por: Giganti, Francesco, et al.
Publicado: (2017)

Simplified Luminal Water Imaging for the Detection of Prostate Cancer From Multiecho T(2) MR Images
por: Devine, William, et al.
Publicado: (2018)

Standardisation of prostate multiparametric MRI across a hospital network: a London experience
por: Papoutsaki, Marianthi-Vasiliki, et al.
Publicado: (2021)

Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathway()
por: Dickinson, Louise, et al.
Publicado: (2013)

Incidence of Second Malignancies for Prostate Cancer
por: Van Hemelrijck, Mieke, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s1qemmljlltu22j6hhr5i74429